Immanuel Klinik Märkische Schweiz

ABC7 Consensus: Assessment by a German Group of Experts (2024) Ditsch N, Untch M, Fasching P, Busch S, Ettl J, Haidinger R, Jackisch C, et al. Journal article Radiotherapy statements of the 18th St. Gallen International Breast Cancer Consensus Conference—a German expert perspective (2024) Krug D, Banys-Paluchowski M, Brucker SY, Denkert C, Ditsch N, Fasching P, Haidinger R, et al. Journal article, Review article Update Breast Cancer 2024 Part 1 - Expert Opinion on Advanced Breast Cancer (2024) Würstlein R, Kolberg HC, Hartkopf AD, Fehm TN, Welslau M, Schütz F, Fasching P, et al. Journal article PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrant (2023) Degenhardt T, Fasching P, Lüftner D, Müller V, Thomssen C, Schem C, Witzel I, et al. Journal article Favorable impact of therapy management by an interactive eHealth system on severe adverse events in patients with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy (2023) Harbeck N, Kates R, Schinköthe T, Schumacher J, Wuerstlein R, Degenhardt T, Lüftner D, et al. Journal article, Review article Update Breast Cancer 2022 Part 6 – Advanced-Stage Breast Cancer (2023) Lüftner D, Lux MP, Fehm TN, Welslau M, Müller V, Schütz F, Fasching P, et al. Journal article, Review article Update Breast Cancer 2022 Part 5 – Early Stage Breast Cancer (2023) Fehm TN, Welslau M, Müller V, Lüftner D, Schütz F, Fasching P, Janni W, et al. Journal article, Review article Update Breast Cancer 2022 Part 4 - Advanced-Stage Breast Cancer. (2022) Aktas B, Fehm TN, Welslau M, Mueller V, Lueftner D, Schuetz F, Fasching P, et al. Journal article, Review article Update Breast Cancer 2022 Part 3 - Early-Stage Breast Cancer. (2022) Fehm TN, Welslau M, Mueller V, Lueftner D, Schuetz F, Fasching P, Janni W, et al. Journal article, Review article Return of individual genomic research results within the PRAEGNANT multicenter registry study (2022) Hübner H, Rübner M, Kurbacher C, Hadji P, Hartkopf AD, Lux MP, Huober J, et al. Journal article